INS and obesity disorder: The potential utility of liver fat percent measured by MRS is highlighted by the finding of patients with 'metabolically-benign' obesity; i.e. obese patients with normal insulin sensitivity and lower liver fat percentages compared to insulin-resistant obese individuals [9].